These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. An evaluation of sodium oxybate as a treatment option for narcolepsy. Abad VC Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215 [No Abstract] [Full Text] [Related]
5. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients. Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923 [TBL] [Abstract][Full Text] [Related]
7. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate]. Poza-Aldea JJ Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563 [TBL] [Abstract][Full Text] [Related]
8. Emerging drugs for narcolepsy. Abad VC; Guilleminault C Expert Opin Emerg Drugs; 2004 Nov; 9(2):281-91. PubMed ID: 15571485 [TBL] [Abstract][Full Text] [Related]
9. The use of sodium oxybate to treat narcolepsy. Mayer G Expert Rev Neurother; 2012 May; 12(5):519-29. PubMed ID: 22550980 [TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of patients with narcolepsy-cataplexy treated with sodium oxybate (Xyrem). Alshaikh MK; Gacuan D; George S; Sharif M; Bahammam AS Clin Neuropharmacol; 2011; 34(1):1-4. PubMed ID: 21206362 [TBL] [Abstract][Full Text] [Related]
11. Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy. Szabo ST; Thorpy MJ; Mayer G; Peever JH; Kilduff TS Sleep Med Rev; 2019 Feb; 43():23-36. PubMed ID: 30503715 [TBL] [Abstract][Full Text] [Related]
12. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate. Huang YS; Guilleminault C Pediatr Neurol; 2009 Jul; 41(1):9-16. PubMed ID: 19520267 [TBL] [Abstract][Full Text] [Related]
14. Sodium oxybate: a review of its use in the management of narcolepsy. Robinson DM; Keating GM CNS Drugs; 2007; 21(4):337-54. PubMed ID: 17381187 [TBL] [Abstract][Full Text] [Related]
15. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials. Boscolo-Berto R; Viel G; Montagnese S; Raduazzo DI; Ferrara SD; Dauvilliers Y Sleep Med Rev; 2012 Oct; 16(5):431-43. PubMed ID: 22055895 [TBL] [Abstract][Full Text] [Related]
16. Criteria for gauging response to sodium oxybate for narcolepsy. Steffen AD; Lai C; Weaver TE J Sleep Res; 2018 Aug; 27(4):e12628. PubMed ID: 29205601 [TBL] [Abstract][Full Text] [Related]
17. Treatment of narcolepsy and other hypersomnias of central origin. Wise MS; Arand DL; Auger RR; Brooks SN; Watson NF; Sleep; 2007 Dec; 30(12):1712-27. PubMed ID: 18246981 [TBL] [Abstract][Full Text] [Related]
18. Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary. Roth T; Thorpy MJ; Kushida CA; Horsnell M; Gudeman J J Comp Eff Res; 2023 Dec; 12(12):e230133. PubMed ID: 37971303 [TBL] [Abstract][Full Text] [Related]
19. Current pharmacologic management of narcolepsy. Scharf MB; Fletcher KA; Jennings SW Am Fam Physician; 1988 Jul; 38(1):143-8. PubMed ID: 3293383 [TBL] [Abstract][Full Text] [Related]
20. Management of narcolepsy. Bhat A; El Solh AA Expert Opin Pharmacother; 2008 Jul; 9(10):1721-33. PubMed ID: 18570605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]